The most prevalent mutations were enriched in the Ras signaling pathway (KRAS, NRAS, FLT3, NF1) and Notch pathway (NOTCH1, FBXW7) in B-ALL and T-ALL, respectively (Fig. 1). Here, KRAS is linked to acute lymphoblastic leukemia.